Nanotechnologies and controlled release formulations for the administration of bisphosphonates and their potential in radiation protection
G Landon, G Phan, F Fay, C Bouvier-Capely… - Journal of Drug Delivery …, 2023 - Elsevier
In the event of internal contamination with radionuclides, decorporating treatment is crucial.
It must be initiated as soon as possible to limit tissue retention of radiocontaminants and …
It must be initiated as soon as possible to limit tissue retention of radiocontaminants and …
Neuro-ophthalmic manifestations of autoimmune disorders: diagnostic pearls & pitfalls
S Poonja, F Costello - Current Opinion in Ophthalmology, 2023 - journals.lww.com
A thorough history, further refined by a comprehensive examination are cornerstones to
disease localization in clinical medicine. Taken together, these essential steps both guide …
disease localization in clinical medicine. Taken together, these essential steps both guide …
A Facile Crystallization Strategy to Turn Calcium Bisphosphonates into Novel Osteogenesis‐Inducing Biomaterials
C Zhuang, G Zhu, Y Wang, L Wang… - Advanced Healthcare …, 2023 - Wiley Online Library
Insoluble metal bisphosphonates (BPs) are considered an ideal alternative to the soluble
counterparts in regenerative medicine due to their increased BP release profile, but still …
counterparts in regenerative medicine due to their increased BP release profile, but still …
VKH-like uveitis during donafenib therapy for hepatocellular carcinoma: a case report and review of the literature
R Liu, G Liu, F Lu - Frontiers in Pharmacology, 2024 - frontiersin.org
Background The incidence of uveitis has risen with the use of targeted therapies, particularly
prevalent in the administration of immune checkpoint inhibitors and MAP-kinase pathway …
prevalent in the administration of immune checkpoint inhibitors and MAP-kinase pathway …
Management of Scleritis in Older Adults
L Butler, O Tomkins-Netzer, O Reiser, RL Niederer - Drugs & Aging, 2024 - Springer
Scleritis, an inflammatory disease of the eye affecting scleral tissue, presents unique
challenges in the older adult population. Unlike their younger counterparts, older individuals …
challenges in the older adult population. Unlike their younger counterparts, older individuals …
Ocular involvement in allergic drug reactions
E Fernandez, E Phillips, HN Saeed - Current Opinion in Allergy …, 2023 - journals.lww.com
Given the consequences of immune-mediated ocular adverse drug reactions, clinicians
must be aware of these to facilitate early recognition and management. The prompt …
must be aware of these to facilitate early recognition and management. The prompt …
Anterior uveitis and diffuse scleritis after pamidronate infusion
JS Xie, AJ Kaplan - CMAJ, 2023 - Can Med Assoc
A 58-year-old, bisphosphonate-naive woman with a history of Hashimoto thyroiditis was
admitted to hospital for hypercalcemia (2.81 [normal 2.20–2.60] mmol/L) due to primary …
admitted to hospital for hypercalcemia (2.81 [normal 2.20–2.60] mmol/L) due to primary …
[HTML][HTML] Bisphosphonate-Induced Orbital Cellulitis in a Patient With Suspected Parathyroid Carcinoma: A Case Report
T McKenna, DE McKenna, V Fernandes, M Korda… - Cureus, 2024 - ncbi.nlm.nih.gov
Bisphosphonates are widely used for a number of metabolic bone conditions. Orbital
inflammation is a very rare side effect of bisphosphonate therapy that can risk permanent …
inflammation is a very rare side effect of bisphosphonate therapy that can risk permanent …
Uvéite antérieure et sclérite diffuse consécutives à une perfusion de pamidronate
JS Xie, AJ Kaplan - CMAJ, 2024 - Can Med Assoc
Figure 1:(A) Uvéite antérieure et sclérite diffuse induites par l'administration de pamidronate
chez une femme de 58 ans. Exophtalmie, hypopion (flèche bleue), et injection et un œdème …
chez une femme de 58 ans. Exophtalmie, hypopion (flèche bleue), et injection et un œdème …
Positive und negative (Neben) Effekte bei Osteoporose-Sequenztherapie
B Obermayer-Pietsch, I Fößl, F Thomasius - Osteologie, 2024 - thieme-connect.com
Indikationen und Abläufe rund um pharmakologischen Optionen für die
Osteoporosetherapie wurden in den vergangenen Jahren neu beleuchtet. Dazu zählen …
Osteoporosetherapie wurden in den vergangenen Jahren neu beleuchtet. Dazu zählen …